Similarly, our in vitro findings revealed that PD treatment lowered inflammatory factor release while enhancing intestinal epithelial barrier function by maintaining the level of TJ protein ZO-1 and occludin, suggesting its potential to mitigate injury caused by DSS-induced colitis. This evidence concerns the gene TJP1 and colitis.